Randomised controlled trial of aripiprazole for treatment of auditory verbal hallucinations in borderline personality disorder

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1102595

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

People with borderline personality disorder (BPD) often report hearing voices. There is no consensus about how to treat these symptoms. Our study aims to address this clinical problem by conducting a 12 week trial of antipsychotic medication in patients who hear voices and have a diagnosis of BPD. The study will examine the effect of this medication on the nature of these voices, as well as other aspects of mental illness and brain functioning. The results will directly inform clinical practice.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2020

Funding Scheme: Project Grants

Funding Amount: $2,748,148.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Psychiatry (incl. Psychotherapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antipsychotic drugs | clinical trial | mental health | personality disorder | psychosis

Related Links